On behalf of the American College of Surgeons Cancer Programs, you are invited to exhibit at the 2024 ACS Cancer Conference: Improving Care for all, a three-day meeting in Austin, TX.
Exhibiting at the 2024 ACS Cancer Conference: Improving Cancer Care for All will expand your market penetration and customer database, providing the opportunity to:
The deadline to reserve a space is February 2, 2024.
$1,800 exhibit fee includes:
Each exhibiting company is entitled to one (1) complimentary exhibitor registration at no additional charge. Exhibits must be staffed during the exhibit hours. Any space not occupied by 7:00 am on Thursday, February 22, 2024, will be forfeited by the exhibitor. Displays may not be dismantled or any packing begun before 11:45 am on Saturday, February 24, 2024. Additional exhibitor badges can be purchased for $500 each.
For more information, please contact one of our exhibit coordinators:
3:00–4:00 pm | Exhibit Set-Up
5:00–6:30 pm | Welcome Reception and Exhibit Kickoff
7:00–8:00 am | Breakfast
10:00–10:15 am | Break
11:30 am–12:30 pm | Lunch
2:15–3:30 pm | Networking Break
7:00–8:00 am | Breakfast
10:00–10:15 am | Networking Break
10:15–11:15 am | Exhibit Teardown
12:00–1:00 pm | Lunch
1:00–1:30 pm | Exhibit Teardown
*Exhibit schedule is subject to change.
In case of cancelation of the ACS Cancer Conference due to high risk of COVID-19 exposure, exhibitors will receive all exhibit space fees paid to ACS Surgeons and Engineers. ACS Cancer Programs is not responsible for any fees paid to third parties.
Exhibitors are responsible for keeping their space sanitized. ACS Cancer Programs will be responsible for sanitizing general areas of the exhibit hall and meeting space.
Written notification of a space cancelation must be received by ACS on or before January 26, 2024 to be eligible for a refund. A $500 service charge will be assessed for each canceled space. No refunds will be given after January 26, 2024.
In the event the exhibition is canceled, postponed, or relocated on account of fire, strikes, government regulations, casualties, Acts of God, or other causes beyond the control of the American College of Surgeons Cancer Programs, the exhibitor waives any and all damages and claim for damages and agrees that the sole liability of ACS Cancer Programs shall be to return each exhibitors the exhibitors's rental payment
Exhibitors must abide by all applicable Food & Drug Administration (FDA) regulations, including, but not limited to, any or all approved requirements. Any product that is an investigational device or an investigational drug must be clearly marked as such. Exhibitors must ensure that with respect to all such devices or drugs, only permissible preapproved dissemination of scientific and educational information is provided at the exhibit and that appropriate disclosures and cautionary notices are included with the devices or drugs. All products and services exhibited shall comply with FDA policy and procedures (particularly with respect to the marketing and labeling of investigational drugs and devices) and other applicable policy and procedures. Exhibitors are reminded that the FDA prohibits the advertising or other promotion of investigational or unapproved drugs and devices. The FDA also forbids the promotion of approved drugs or devised for unapproved uses. In addition, under FDA rules, the background of the exhibit must show the generic name of any drug product featured. For additional information, contact the FDA at 888-463-6332 or visit fda.gov.